MET and cancer: It is well known that HGF/c-MET signaling activates MAPK cascades enhancing cancer cell proliferation and Akt cascades increasing the anti-apoptotic effects, which could eventually increase the drug tolerance capacity in various cancers (Xiao et al. 2001).